Nanjing Vazyme Biotech Co., Ltd. (688105.SS)
CNY 24.88
(-0.4%)
CNY 24.88
(-0.4%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.28 Billion CNY | 180.92% |
| 2022 | 458.14 Million CNY | 402.45% |
| 2021 | 91.18 Million CNY | 7823.56% |
| 2020 | 1.15 Million CNY | -96.78% |
| 2019 | 35.68 Million CNY | 14.53% |
| 2018 | 31.16 Million CNY | 462.07% |
| 2017 | 5.54 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 456.77 Million CNY | -12.44% |
| 2024 Q1 | 1.09 Billion CNY | -14.75% |
| 2024 Q2 | 703.38 Million CNY | -35.89% |
| 2023 Q2 | 1.32 Billion CNY | 11.3% |
| 2023 FY | 1.28 Billion CNY | 180.92% |
| 2023 Q4 | 1.28 Billion CNY | -1.46% |
| 2023 Q3 | 1.3 Billion CNY | -1.3% |
| 2023 Q1 | 1.18 Billion CNY | 159.53% |
| 2022 Q2 | 198.5 Million CNY | 60.0% |
| 2022 Q1 | 124.06 Million CNY | 36.06% |
| 2022 FY | 458.14 Million CNY | 402.45% |
| 2022 Q4 | 458.14 Million CNY | 9.73% |
| 2022 Q3 | 417.52 Million CNY | 110.34% |
| 2021 FY | 91.18 Million CNY | 7823.56% |
| 2021 Q2 | 89.5 Million CNY | 0.0% |
| 2021 Q4 | 91.18 Million CNY | 12.06% |
| 2021 Q3 | 81.36 Million CNY | -9.09% |
| 2021 Q1 | - CNY | -100.0% |
| 2020 FY | 1.15 Million CNY | -96.78% |
| 2020 Q4 | 1.15 Million CNY | 0.0% |
| 2020 Q2 | 43.1 Million CNY | 0.0% |
| 2019 FY | 35.68 Million CNY | 14.53% |
| 2018 FY | 31.16 Million CNY | 462.07% |
| 2017 FY | 5.54 Million CNY | 0.0% |